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Introduction
Several studies have linked cytokine levels to severity of
sepsis and outcome, but the relative timing of biomarker
levels, the septic process and outcomes is often unclear.
Objectives
To determine whether there exists endotypes of sepsis
defined by biomarker trajectories, and whether types of
trajectories are associated with 60-day mortality.
Methods
The Protocol-based Care in Early Septic Shock (ProCESS)
trial prospectively enrolled 1341 patients with sepsis hav-
ing a 19.3% 60-day mortality (Yealy et al., 2014). Biomar-
ker levels were obtained soon after enrollment (t = 0) and
at 6, 24 and 72 hours in a convenience cohort of 638
patients having 17.1% mortality. We used trajectory analy-
sis to cluster IL-6, IL-10, and joined IL-6 and IL-10 trajec-
tories in the 638 patients having at least one measurement
of IL-6 or IL-10, in patients with markers rising between 0
and 6 hours (presumably earlier in the course of sepsis),
and in patients with monotonically decreasing biomarker
levels (presumably later in the course of sepsis). Trajec-
tories were described as increasing from t = 0 to 6 hours,
decreasing or flat. 60-day mortality was compared between
clusters to determine the association between cytokine tra-
jectory and mortality.
Results
600 patients had measurements at 0 and 6 hours, 570 had
at least 3 measurements, but only 170 patients had mea-
surements at all time-points. There was no association
between stated times of first symptoms (average 4.0 days),
times between emergency department arrival and enrol-
ment (average 3.1 hours) and whether trajectories were
increasing or decreasing at the first two time points. Com-
paring trajectory types of the first two time points (t = 0
and 6), patients with rising profiles of both IL-6 and IL-10
had the highest mortality (30.8%, Table), followed by
patients with either rising IL-10 (25.8%) or rising IL-6
(27.9%). In trajectory analysis of all four time-points, the
cluster of patients with elevated levels of both cytokines
and blunted decreases had the highest mortality (>50%).
Patients with high cytokine level at enrollment but rapidly
decreasing levels of IL-6 had a favorable outcome. Flat and
persistently low trajectories were associated with the low-
est mortality. There exists a significant cohort of patients
with a minimal cytokine response that died, and a smaller
cohort of patients with vigorous and sustained response,
that survived.
Conclusions
In this exploratory analysis, patients with rising levels of
cytokines, or persistently elevated levels of cytokines at
t≤6 hours are at high risk of mortality. Endotypes of
patients with unexpected outcomes, non-survivors with
blunted cytokine response, or survivors with exuberant
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Table 1
IL-6 increasing 191 (23.6%) IL-6 decreasing 359 (13.9%) IL-6 flat 50 (6.0%)
IL-10 increasing 147 (29.3%) 78 (30.8%) 68 (27.9%) 1 (0%)
IL-10 decreasing 297 (15.5%) 62 (25.8%) 222 (12.6%) 13 (15.6%)
IL-10 flat 155 (5.8%) 51 (9.8%) 69 (4.3%) 35 (2.9%)
[T = 0 to 6 hours trends: N of patients (mortality%)]
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